In its latest Form 13F filing, Braun Stacey Associates Inc. raised its stake in CME by 8.2% during the third quarter, adding 7,336 shares to reach a total holding of 97,254 shares valued at 26.28 million. This move contrasts with more modest adjustments from peers: Jessup Wealth Management increased its position by 0.5% to 7,969 shares, First Horizon Advisors added 0.7% to 5,269 shares, Great Lakes Advisors lifted its holding by 2.3% to 1,661 shares, MBM Wealth Consultants upped its stake by 2.7% to 1,422 shares, and Beaumont Financial Advisors grew its position by 2.0% to 1,952 shares. Collectively, institutional investors now account for 87.75% of CME’s outstanding shares, underscoring broad confidence in the derivatives exchange operator’s long-term prospects.

CME reported third-quarter earnings per share of 2.68, beating consensus by 0.05 and matching the prior-year quarter, while revenue came in at 1.54 billion, falling short of estimates by 20 million and marking a 3.0% year-over-year decline. Net margin remained robust at 58.8%, and return on equity held at 14.6%. Following the earnings release, the company paid a quarterly dividend of 1.25 per share to investors of record as of December 12, representing an annualized payout of 5.00 and a yield near 1.8%. The dividend payout ratio stands at 48.5%, reflecting disciplined capital allocation amid modest revenue pressures in core futures and options trading.

Insider selling intensified late in the fourth quarter: CEO Terrence A. Duffy reduced his holding by 27.5%, disposing of 25,000 shares, while Director Harold Eugene Jr. lowered his stake by 47.8% with a 1,000-share sale. Corporate insiders now collectively hold 0.30% of shares. On the research front, analysts remain divided: eight recommend buy, seven advise hold and three issue sell opinions. Price targets range from a low of 263 to a high of 318, with an average consensus at approximately 290.8. Recent adjustments include a reduction from 313 to 304 by Jefferies and an upgrade from 310 to 318 by Deutsche Bank, signaling a mixed outlook balanced between valuation concerns and the firm’s leading market position.